---
title: "China Meheco: Net profit of 294 million yuan in the first half of 2025, a year-on-year decrease of 16.19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254776403.md"
description: "China Meheco announced that in the first half of 2025, operating revenue was 17.076 billion yuan, a year-on-year decrease of 6.71%; net profit was 294 million yuan, a year-on-year decrease of 16.19%. The company plans to distribute a cash dividend of 0.1966 yuan for every 10 shares to all shareholders, with a total profit distribution of 29.409 million yuan"
datetime: "2025-08-27T09:49:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254776403.md)
  - [en](https://longbridge.com/en/news/254776403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254776403.md)
---

# China Meheco: Net profit of 294 million yuan in the first half of 2025, a year-on-year decrease of 16.19%

China Meheco announced that in the first half of 2025, operating revenue was 17.076 billion yuan, a year-on-year decrease of 6.71%; net profit was 294 million yuan, a year-on-year decrease of 16.19%. The company plans to distribute a cash dividend of 0.1966 yuan for every 10 shares to all shareholders, with a total profit distribution of 29.409 million yuan

### Related Stocks

- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)

## Related News & Research

- [EXPLAINER-What is Unitree and why are China’s humanoid robot makers racing to list?](https://longbridge.com/en/news/295349610.md)
- [Unitree IPO Frenzy Leaves Retail Investors Scrambling as Over 70% of Shares Go to Institutions](https://longbridge.com/en/news/295656794.md)
- [Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection](https://longbridge.com/en/news/295637927.md)
- [15:03 ETMNA: MGB Refuses to Schedule More Negotiations or Make Any Proposals to Brigham Nurses in Third Session Following Historic Strike](https://longbridge.com/en/news/295569711.md)
- [SHUKRAPHAR: Strong revenue and profit growth in Q1 FY27, with robust performance in the pharmaceutical segment](https://longbridge.com/en/news/295639972.md)